-
1
-
-
0000460541
-
Leukotrienes
-
Holgate ST, Busse WW, eds. New York, NY: Marcel Dekker Inc.
-
1 Dahlén S-E. Leukotrienes. In: Holgate ST, Busse WW, eds. Inflammatory Mechanisms in Asthma. New York, NY: Marcel Dekker Inc., 1998:679-733.
-
(1998)
Inflammatory Mechanisms in Asthma
, pp. 679-733
-
-
Dahlén, S.-E.1
-
2
-
-
0024477342
-
4 after antigen challenge and in acute asthma and allergic rhinitis
-
4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989; 1:584-8.
-
(1989)
Lancet
, vol.1
, pp. 584-588
-
-
Taylor, G.W.1
Taylor, I.2
Black, P.3
-
3
-
-
0025922730
-
4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate
-
4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am Rev Respir Dis 1991; 143:1322-8.
-
(1991)
Am Rev Respir Dis
, vol.143
, pp. 1322-1328
-
-
Westcott, J.Y.1
Smith, H.R.2
Wenzel, S.E.3
-
7
-
-
0026644731
-
4, and histamine in asthmatics
-
4, and histamine in asthmatics. Am Rev Respir Dis 1992; 146:96-103.
-
(1992)
Am Rev Respir Dis
, vol.146
, pp. 96-103
-
-
Kumlin, M.1
Dahlen, B.2
Björck, T.3
Zetterström, O.4
Granström, E.5
Dahlén, S.-E.6
-
9
-
-
0025892285
-
4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects
-
4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143:1025-9.
-
(1991)
Am Rev Respir Dis
, vol.143
, pp. 1025-1029
-
-
Christie, P.E.1
Tagari, P.2
Ford-Hutchinson, A.W.3
-
11
-
-
0027172447
-
The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics
-
11 Dahlén B, Kumlin M, Margolskee DJ et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 1993; 6:1018-26.
-
(1993)
Eur Respir J
, vol.6
, pp. 1018-1026
-
-
Dahlén, B.1
Kumlin, M.2
Margolskee, D.J.3
-
12
-
-
0028821025
-
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo
-
12 Diamant Z, Timmers MC, van der Veen H et al. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995; 95:42-51.
-
(1995)
J Allergy Clin Immunol
, vol.95
, pp. 42-51
-
-
Diamant, Z.1
Timmers, M.C.2
Van Der Veen, H.3
-
13
-
-
0030944646
-
Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics
-
13 Roquet A, Dahlén B, Kumlin M et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997; 155:1856-63.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 1856-1863
-
-
Roquet, A.1
Dahlén, B.2
Kumlin, M.3
-
14
-
-
0026078163
-
Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients
-
14 Hui KP, Taylor IK, Taylor GW et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991; 46:184-9.
-
(1991)
Thorax
, vol.46
, pp. 184-189
-
-
Hui, K.P.1
Taylor, I.K.2
Taylor, G.W.3
-
15
-
-
0027458882
-
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses
-
15 Friedman BS, Bel EH, Buntinx A et al. Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis 1993; 147:839-44.
-
(1993)
Am Rev Respir Dis
, vol.147
, pp. 839-844
-
-
Friedman, B.S.1
Bel, E.H.2
Buntinx, A.3
-
16
-
-
0030925781
-
Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005
-
16 Dahlén B, Kumlin M, Ihre E, Zetterström O, Dahlén S-E. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYX 1005. Thorax 1997; 52:342-7.
-
(1997)
Thorax
, vol.52
, pp. 342-347
-
-
Dahlén, B.1
Kumlin, M.2
Ihre, E.3
Zetterström, O.4
Dahlén, S.-E.5
-
17
-
-
0031797328
-
Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions
-
17 O'Sullivan S, Roquet A, Dahlén B, Larsson L, Dahlén S-E, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998; 28:1332-9.
-
(1998)
Clin Exp Allergy
, vol.28
, pp. 1332-1339
-
-
O'Sullivan, S.1
Roquet, A.2
Dahlén, B.3
Larsson, L.4
Dahlén, S.-E.5
Kumlin, M.6
-
18
-
-
0028327560
-
The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics
-
18 Dahlén B, Zetterström O, Björck T, Dahlén S-E. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Eur Respir J 1994; 7:324-31.
-
(1994)
Eur Respir J
, vol.7
, pp. 324-331
-
-
Dahlén, B.1
Zetterström, O.2
Björck, T.3
Dahlén, S.-E.4
-
19
-
-
0029063425
-
Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans
-
19 Kumlin M, Stensvad F, Larsson L, Dahlén B, Dahlén S-E. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans. Clin Exp Allergy 1995; 25:467-79.
-
(1995)
Clin Exp Allergy
, vol.25
, pp. 467-479
-
-
Kumlin, M.1
Stensvad, F.2
Larsson, L.3
Dahlén, B.4
Dahlén, S.-E.5
-
20
-
-
0027419575
-
Reversible translocation of 5-lipoxygenase in mast cells upon IgE/antigen stimulation
-
20 Malaviya R, Malaviya R, Jakschik BA. Reversible translocation of 5-lipoxygenase in mast cells upon IgE/antigen stimulation. J Biol Chem 1993; 268:4939-44.
-
(1993)
J Biol Chem
, vol.268
, pp. 4939-4944
-
-
Malaviya, R.1
Malaviya, R.2
Jakschik, B.A.3
|